Core Viewpoint - GoHealth reported a quarterly loss of 3.73pershare,whichwasworsethantheZacksConsensusEstimateofalossof3.19, and a significant increase from a loss of 2.61pershareayearago,indicatingongoingfinancialchallengesforthecompany[1]FinancialPerformance−GoHealth′srevenuesforthequarterendedSeptember2024were118.29 million, exceeding the Zacks Consensus Estimate by 11.67%, but down from 132.04millioninthesamequarterlastyear[2]−Overthelastfourquarters,GoHealthhassurpassedconsensusEPSestimatesonlyonce[2]StockPerformance−GoHealthshareshavedeclinedapproximately4.41.50 for the upcoming quarter and -$5.35 for the current fiscal year [4][7] - The estimate revisions trend for GoHealth is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The Insurance - Life Insurance industry, to which GoHealth belongs, is currently ranked in the top 20% of over 250 Zacks industries, indicating a favorable industry outlook that could positively influence GoHealth's performance [8]